Results 71 to 80 of about 5,973 (205)
British Journal of Pharmacology, Volume 183, Issue 16, Page 4646-4662, August 2026.Abstract Background and Purpose Ventricular fibrillation (VF) in coronary heart disease accounts for up to 70% of sudden cardiac death. We examined whether diltiazem N‐oxide (DNO) has ischaemia‐selective antiarrhythmic activity. Experimental Approach Randomised and blinded experiments were performed in rat isolated hearts and in anaesthetised rats to ...
Louise M. Hesketh +5 more
wiley +1 more source
Oral propafenone as treatment for incessant supraventricular and ventricular tachycardia in children
, 1993 Incessant tachycardia, which can result in tachycardiainduced cardiomyopathy, is difficult to treat with conventional drugs. Better results are obtained with class Ic antiarrhythmic agents, but they may elicit proarrhythmias.
Bink - Boelkens, MTE, Beaufort-Crol, GCM
core +1 more source
Кардиоваскулярная терапия и профилактика, 1970 Aim. To study clinical effectiveness and safety of propafenone and amiodarone in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with preserved left ventricular (LV) systolic function, and atrial ...
Yu. M. Pozdnyakov +3 more
doaj
Propafenone overdose: Cardiac arrest and full recovery [PDF]
, 2010 Intoxication caused by propafenone is very rare, and there are no known detailed epidemiological studies. We present the clinical manifestation of severe propafenone intoxication,successfully treated in a 17 year-old male. He was brought to the Intensive
Wożakowska-Kapłon, Beata; 1st Clinical Department of Cardiology, Swietokrzyskie Centre of Cardiology, Kielce, Poland +1 more
core
Propafenone effects on the stable structures of A beta(16-22) system
, 2018 © 2018 Elsevier B.V. An extensive replica exchange molecular dynamics (REMD) simulation was performed to investigate the progress patterns of the molecular interactions of propafenone and Aβ16-22 system.
Ngo, Son Tung, Linh, Tran, Nguyen, Minh
core +1 more source
Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia [PDF]
, 1987 Propafenone was administered during electrophysiologic testing to determine its efficacy and safety for terminating and preventing reinduction of paroxysmal supraventricular reentrant tachycardia. Four men and 10 women (mean age 50 years, range 28 to 69)
McLaran, Christopher J. +5 more
core +1 more source
Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia [PDF]
, 1984 Electrophysiologic and hemodynamic studies were performed before and after intravenous infusion of a new antiarrhythmic agent, propafenone, in 28 patients with recurrent ventricular tachycardia.
Shapiro, William +6 more
core +1 more source
, 2006 A robust, inexpensive, and fully validated CE method for the simultaneous determination of the enantiomers of propafenone (PPF), 5-hydroxy-propafenone (5OH-PPF) and N-despropyl-propafenone (NOR-PPF) in serum and in in vitro media is described.
Thormann, Wolfgang, Afshar, Minoo
core +1 more source
Кардиоваскулярная терапия и профилактика, 1970 Aim. To study effectiveness and safety of combined propafenone and lisinopril therapy for sinus rhythm (SR) maintenance in patients with persistent atrial fibrillation (AF) and arterial hypertension (AH). Material and methods.
R. G. Oganov +2 more
doaj
Кардиоваскулярная терапия и профилактика, 2005 Aim. To study efficacy and safety of propafenone (loading single dose of 600 mg per os) in treating atrial fibrillation (AF) paroxysms. Material and methods. The study included 233 patients with persistent AF, aged 31-62 (mean age 57.6 ± 2.8 years), from
I. G. Fomina +3 more
doaj